Foerster KI - Search Results

1

IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.

Sadik A, Somarribas Patterson LF, Öztürk S, Mohapatra SR, Panitz V, Secker PF, Pfänder P, Loth S, Salem H, Prentzell MT, Berdel B, Iskar M, Faessler E, Reuter F, Kirst I, Kalter V, Foerster KI, Jäger E, Guevara CR, Sobeh M, Hielscher T, Poschet G, Reinhardt A, Hassel JC, Zapatka M, Hahn U, von Deimling A, Hopf C, Schlichting R, Escher BI, Burhenne J, Haefeli WE, Ishaque N, Böhme A, Schäuble S, Thedieck K, Trump S, Seiffert M, Opitz CA. Sadik A, et al. Among authors: foerster ki. Cell. 2020 Sep 3;182(5):1252-1270.e34. doi: 10.1016/j.cell.2020.07.038. Epub 2020 Aug 19. Cell. 2020. PMID: 32818467 Free article.

2

Clinical feasibility of dried blood spots: Analytics, validation, and applications.

Enderle Y, Foerster K, Burhenne J. Enderle Y, et al. J Pharm Biomed Anal. 2016 Oct 25;130:231-243. doi: 10.1016/j.jpba.2016.06.026. Epub 2016 Jun 23. J Pharm Biomed Anal. 2016. PMID: 27390013 Review.

3

Simultaneous quantification of direct oral anticoagulants currently used in anticoagulation therapy.

Foerster KI, Huppertz A, Müller OJ, Rizos T, Tilemann L, Haefeli WE, Burhenne J. Foerster KI, et al. J Pharm Biomed Anal. 2018 Jan 30;148:238-244. doi: 10.1016/j.jpba.2017.10.011. Epub 2017 Oct 16. J Pharm Biomed Anal. 2018. PMID: 29055248

4

Dried-Blood-Spot Technique to Monitor Direct Oral Anticoagulants: Clinical Validation of a UPLC-MS/MS-Based Assay.

Foerster KI, Huppertz A, Meid AD, Müller OJ, Rizos T, Tilemann L, Haefeli WE, Burhenne J. Foerster KI, et al. Anal Chem. 2018 Aug 7;90(15):9395-9402. doi: 10.1021/acs.analchem.8b02046. Epub 2018 Jul 17. Anal Chem. 2018. PMID: 29985592

5

Rivaroxaban and macitentan can be coadministered without dose adjustment but the combination of rivaroxaban and St John's wort should be avoided.

Huppertz A, Werntz L, Meid AD, Foerster KI, Burhenne J, Czock D, Mikus G, Haefeli WE. Huppertz A, et al. Among authors: foerster ki. Br J Clin Pharmacol. 2018 Dec;84(12):2903-2913. doi: 10.1111/bcp.13757. Epub 2018 Oct 11. Br J Clin Pharmacol. 2018. PMID: 30192025 Free PMC article. Clinical Trial.

6

Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug-Drug Interactions with Potential Perpetrator Drugs.

Mikus G, Foerster KI, Schaumaeker M, Lehmann ML, Burhenne J, Haefeli WE. Mikus G, et al. Among authors: foerster ki. Clin Pharmacokinet. 2019 Sep;58(9):1155-1163. doi: 10.1007/s40262-019-00749-1. Clin Pharmacokinet. 2019. PMID: 30828771 Clinical Trial.

7

Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers.

Brings A, Lehmann ML, Foerster KI, Burhenne J, Weiss J, Haefeli WE, Czock D. Brings A, et al. Among authors: foerster ki. Br J Clin Pharmacol. 2019 Jul;85(7):1528-1537. doi: 10.1111/bcp.13934. Epub 2019 May 9. Br J Clin Pharmacol. 2019. PMID: 30912163 Free PMC article. Clinical Trial.

8

Prolonged-Release Tacrolimus Is Less Susceptible to Interaction With the Strong CYP3A Inhibitor Voriconazole in Healthy Volunteers.

Huppertz A, Ott C, Bruckner T, Foerster KI, Burhenne J, Weiss J, Zorn M, Haefeli WE, Czock D. Huppertz A, et al. Among authors: foerster ki. Clin Pharmacol Ther. 2019 Dec;106(6):1290-1298. doi: 10.1002/cpt.1529. Epub 2019 Jul 10. Clin Pharmacol Ther. 2019. PMID: 31152598

9

An ultra-sensitive UHPLC-MS/MS assay for the quantification of orally administered vancomycin in plasma.

Sauter M, Uhl P, Foerster KI, Mohr I, Höne RT, Merle U, Burhenne J, Haefeli WE. Sauter M, et al. Among authors: foerster ki. J Pharm Biomed Anal. 2019 Sep 10;174:633-638. doi: 10.1016/j.jpba.2019.06.015. Epub 2019 Jun 27. J Pharm Biomed Anal. 2019. PMID: 31279892

10

Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways.

Huppertz A, Grond-Ginsbach C, Dumschat C, Foerster KI, Burhenne J, Weiss J, Czock D, Purrucker JC, Rizos T, Haefeli WE. Huppertz A, et al. Among authors: foerster ki. BMC Pharmacol Toxicol. 2019 Aug 29;20(1):53. doi: 10.1186/s40360-019-0331-9. BMC Pharmacol Toxicol. 2019. PMID: 31464657 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page